Ambiguous And Stifling: Pharma On ICH Bioanalytical Method Validation Guide
Executive Summary
EU pharma is concerned that certain proposals in a new international guideline on bioanalytical method validation could be overinterpreted, increase burden on companies and stifle ‘scientific freedom.’